MACITENTAN for Portopulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 153 adverse event reports in the FDA FAERS database where MACITENTAN was used for Portopulmonary hypertension.
Most Reported Side Effects for MACITENTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 8,315 | 18.4% | 1,685 | 5,903 |
| Death | 5,864 | 12.9% | 5,789 | 2,120 |
| Headache | 4,856 | 10.7% | 575 | 2,694 |
| Diarrhoea | 3,669 | 8.1% | 574 | 2,268 |
| Pneumonia | 3,531 | 7.8% | 810 | 3,162 |
| Nausea | 3,463 | 7.6% | 456 | 2,116 |
| Hospitalisation | 3,414 | 7.5% | 500 | 3,372 |
| Fatigue | 3,172 | 7.0% | 485 | 1,899 |
| Fluid retention | 2,861 | 6.3% | 575 | 2,150 |
| Dizziness | 2,704 | 6.0% | 337 | 1,673 |
| Malaise | 2,521 | 5.6% | 431 | 1,590 |
| Pulmonary arterial hypertension | 2,390 | 5.3% | 1,204 | 1,695 |
| Hypotension | 2,318 | 5.1% | 519 | 1,691 |
| Cough | 2,294 | 5.1% | 314 | 1,404 |
| Condition aggravated | 2,198 | 4.9% | 638 | 1,538 |
Other Indications for MACITENTAN
Pulmonary arterial hypertension (29,246)
Product used for unknown indication (9,498)
Pulmonary hypertension (5,228)
Cor pulmonale chronic (254)
Connective tissue disorder (107)
Systemic scleroderma (74)
Pulmonary embolism (68)
Heart disease congenital (56)
Heritable pulmonary arterial hypertension (43)
Right-to-left cardiac shunt (32)
Other Drugs Used for Portopulmonary hypertension
AMBRISENTAN (428)
EPOPROSTENOL (52)
TREPROSTINIL (46)
SELEXIPAG (35)
LETAIRIS (29)
SILDENAFIL (29)
BOSENTAN (26)
TADALAFIL (16)
BOSENTAN\BOSENTAN (10)
VELETRI (8)